 |

Last
updated: January 9, 2012
Cancer
Immunity (ISSN 1424-9634) is a free, peer-reviewed
journal focusing on the immune response to cancer.
Publishing since: 2001
Manuscript rejection rate: 40% (2011)
Circulation: 56,105 distinct hosts (2010)
Indexed/covered by: MEDLINE/Index Medicus,
Google Scholar,
Elsevier's Scopus
and Embase, MerkMedicus,
Genamics JournalSeek,
OpenJGate, WHO's
HINARI, DOAJ,
Ulrich's International Periodical Directory,
Reactions Weekly
CWTS Journal
Indicator: SNIP 0.80 (2011)
SNIP (Source-Normalized Impact per Paper) measures
contextual citation impact by weighting citations based
on the total number of ciatations in a subject field
SCImago Journal
Rank (SJR): H index 24, Cancer Research 48 of 173 (2011),
Immunology 50 of 190 (2011)
H index corresponds to the journal's number of articles
(h) that have received at least h citations over the whole
period

|
|
Scope
Editorial Board
Instructions to Authors
- instructions on how to prepare a manuscript for submission
Standard Abbreviations
- abbreviations used without definition in the journal
Citation - how to cite papers published
in the journal
Linking - linking to the journal
Copyright - proprietory rights notice for the journal
Privacy Policy - how your data is handled
Disclaimer
Site Map
|
|
|
Citation
As
an online journal, Cancer Immunity
does not have issue numbers. Each volume corresponds to a calendar
year.
Articles
published in Cancer Immunity
should be cited in the same way as articles in traditional journals.
However, because articles in this journal are published online
and are not printed, they have a unique page number and
an URL.
The
following citation:
Old LJ. Cancer/Testis (CT) antigens - a new link between gametogenesis
and cancer. Cancer Immun [serial online] 2001; 1:1.
URL: http://www.cancerimmunity.org/v1p1/010304.htm
refers
to the article on page 1 of volume 1 of the journal.
|
Linking
Links
to the journal (URL: http://www.cancerimmunity.org) or to individual
pages of the journal are welcome. Notification
would be greatly appreciated.
|
Copyright
Unless
otherwise noted, you may view, copy, download, and print documents
from the Cancer Immunity
Web site as long as you use them only for research or educational
purposes and do not post, distribute, or modify them or remove
any copyright, trademark, or other proprietary notices.
Commercial
use of the Cancer Immunity
Web site or the articles published therein is expressly prohibited
without the written consent of the copyright holder. For permission
to use material copyrighted by the Academy of Cancer Immunology,
please contact the Editorial Office.
For
permission to use material in papers copyrighted by the authors,
please refer to the contact information provided in the original
paper.
Cancer
Immunity is the
copyright holder to the collective work.
|
Privacy
Cancer Immunity is
committed to respecting the privacy and anonymity of its Web site
users.
Cookies
are not used and users are not required to register. Information
provided voluntarily by users (name, e-mail address or any other
contact information) is securely stored and not shared with any
third party.
For
site management and statistical purposes, information is collected
through standard Web logs. These Web logs contain the domain name
or IP address from which users connect, the date and time of access,
search terms and the pages visited.
|
Disclaimer
Authors assume responsibility for the propriety and scientific
standard of the manuscripts they submit for publication. The opinions
expressed by authors contributing to this journal do not necessarily
reflect the opinions of the Academy of Cancer Immunology. Cancer
Immunity does not assume any liability for the
content of Web sites linked to this site.
|
|
 |